Evidence map›Paper›PMID 42161657›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2026

[First-line treatment for chronic graft-versus-host disease: a real-world study].

X Q Dong, Y D He, S Q Huang, X Q Wang, R H Huang, X Zhang

Abstract readEnglish Abstract
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

X Q DongMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing Key Laboratory of Hematology and Microenvironment, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing 400037, China Jinfeng Laboratory, Chongqing 400037, China.
Y D HeMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing Key Laboratory of Hematology and Microenvironment, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing 400037, China.
S Q HuangMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing Key Laboratory of Hematology and Microenvironment, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing 400037, China.
X Q WangMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing Key Laboratory of Hematology and Microenvironment, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing 400037, China.
R H HuangMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing Key Laboratory of Hematology and Microenvironment, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing 400037, China.
X ZhangMedical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing Key Laboratory of Hematology and Microenvironment, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing 400037, China Jinfeng Laboratory, Chongqing 400037, China.

Funding

Chongqing Medical Scientific Research project (Joint project of Chongqing Health Commission and Science and Technology Bureau) 2025CCXM002National Natural Science Foundation of China 82020108004, 82341201Special Project for Talent Construction in Xinqiao Hospital of Army Medical University 2024XKRC009, 2022XKRC001The National Key R&D Program of China 2022YFA1103300, 2022YFA1103304
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseAdultChronic DiseaseFemaleHumansMaleMiddle AgedQuality of LifeRetrospective StudiesTreatment OutcomeChronic graft-versus-host diseaseEfficacyFirst-line treatmentOrgan responseSymptom burden

Identifiers

PMID42161657
PMCPMC13195549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.